Back to MORGAN STANLEY MORGAN STANLEY

RCUSRCUS
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in Arcus Biosciences, Inc.

MORGAN STANLEY holds 795,912 shares of RCUS (Arcus Biosciences, Inc.), worth $24.5M as of 2026-Q2. The position was decreased (-28.5% shares). RCUS represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$24.5M

Current Shares

795,912

Total Value Change

+$13.6M

Total Shares Change

+81,456

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
795,912
-28.5%
$24.5M0.0%$30.83
0
2026-Q1
Decreased
1.1M
-8.0%
$24.1M0.0%$22.43
0
2025-Q4
Decreased
1.2M
-21.2%
$28.9M0.0%$23.23
0
2025-Q3
Increased
1.5M
+4.5%
$20.9M0.0%$13.32
30
2025-Q2
Increased
1.5M
+86.7%
$12M0.0%$7.95
43
2025-Q1
Increased
787,080
+43.1%
$6.2M0.0%$8.17
37
2024-Q4
Decreased
549,914
-23.0%
$8.2M0.0%$14.91
0
2024-Q3
Increased
714,456
+60.2%
$10.9M0.0%$15.41
40

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used